Dr. Reddy's Plant Charged with Major Deficiencies

Aug 14, 2017

RAPS

Regulators in the Central Authority for Supervision of Medicinal Products in Bavaria have charged a Hyderabad, India-based manufacturing site run by Dr. Reddy's Laboratories with non-compliance of good manufacturing practices, according to RAPS.

Based on an August inspection, the non-compliance report says the plant had one critical deficiency related to important elements of its quality system. The facility manufactures and packages non-sterile capsules and tablets, the story said, and regulators asked that they not supply product to the EU until there is a successful re-inspection.

Read the full article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments